Oxford Immunotec Company

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT√В¬Ѓ.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Funding Status: M&A
Headquarters: Abingdon, Oxfordshire, United Kingdom
Founded Date: 01.01.2002
Investor Type: N/A
Investment Stage: N/A
Technology: Genetic Test & Molecular Diagnostics
Employee Number: 501-1000
Number Of Exists: N/A
Estimated Revenue: $10M to $50M
Industry: Deep Diagnostics